Manifestations of enterovirus D68 and high seroconversion among children attending a kindergarten

Ya-Li Hu1, Li-Min Huang1, Chun-Yi Lu1

  • 1Department of Pediatrics, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.

Insights

Enterovirus D68 (EV-D68) shows high susceptibility in young children, with a 73% seroconversion rate observed in a kindergarten study. This highlights the need for preventive measures in childcare settings to curb transmission.

Area of Science:

  • Virology
  • Epidemiology
  • Pediatrics

Background:

  • Enterovirus D68 (EV-D68) is an emerging infectious disease primarily affecting children.
  • Limited research exists on EV-D68 transmission and seroprevalence in daycare and kindergarten settings.

Purpose of the Study:

  • To investigate respiratory viral transmission of EV-D68 among preschool children.
  • To determine EV-D68 seroprevalence and seroconversion rates in a kindergarten population.

Main Methods:

  • A prospective cohort study was conducted in a Taipei City public kindergarten from September 2006 to June 2008.
  • Daily illness monitoring and biweekly physical examinations were performed.
  • Viral isolation and neutralization tests were used to detect acute EV-D68 infection and specific antibodies.

Main Results:

  • Nine children (4.7%) among 190 attendees aged 2-5 years had acute EV-D68 infection.
  • Clinical symptoms included pharyngitis and upper respiratory tract infections; no severe cases or paralysis were reported.
  • EV-D68 seropositive rates increased from 19% to 67%, with a 73% seroconversion rate in initially seronegative children.

Conclusions:

  • Preschool-aged children exhibit high susceptibility to EV-D68, indicated by a significant seroconversion rate.
  • The disease burden of EV-D68 may be underestimated in childcare settings.
  • Preventive strategies are recommended for kindergartens and daycares to reduce EV-D68 transmission and severe outcomes.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
265
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
788
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
211
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
490
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
319
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
590